Table 2 Drug therapy for peripheral artery disease and lifestyle changes
Visit I (baseline) (n = 1015) % | Visit II (3 months) (n = 1015) % | Visit III (6 months) (n = 1015) % | P value | |
|---|---|---|---|---|
Treatment for intermittent claudication [n (%)] | ||||
50 mg cilostazol | 466 (45.9) | 337 (34.2) | 319 (32.5) | < 0.01 |
100 mg cilostazol | 546 (53.8) | 648 (65.8) | 663 (67.5) | < 0.01 |
Pentoxifylline | 14 (1.4) | 0 (0) | 0 (0) | – |
Acetylsalicylic acid | 212 (20.9) | 318 (32.3) | 322 (32.8) | < 0.01 |
Clopidogrel | 150 (14.8) | 224 (22.7) | 223 (22.7) | < 0.01 |
Lifestyle change [n (%)] | ||||
Smoking cessation | 0 (0.0) | 768 (78.0) | 809 (82.4) | < 0.01 |
Exercise increase | 0 (0.0) | 742 (75.3) | 769 (78.3) | < 0.01 |